Advertisement

Indian Journal of Surgical Oncology

, Volume 9, Issue 4, pp 456–460 | Cite as

Recent Strategies and Paradigm Shift in Management of Hepatic Metastasis from Colorectal Cancer

  • Shekhar GognaEmail author
  • Priya Goyal
Review Article
  • 24 Downloads

Abstract

The liver is the most common site for metastasis from colorectal cancers (CRCs). There are so many new armamentarium, which have increased the life expectancy and progression-free survival. There are various available guidelines, such as NCCN, ESMO, and ASCO, which provide an insight into the latest modalities and new protocols. We have tried to elucidate into paradigm shift of the management.

Keywords

Colorectal cancer Hepatic metastasis Multimodal treatment 

References

  1. 1.
    Misiakos EP, Karidis NP, Kouraklis G (2011) Current treatment for colorectal liver metastases. World J Gastroenterol 17(36):4067–4075CrossRefGoogle Scholar
  2. 2.
    Scheele J, Stangl R, Altendorf-Hofmann A (1990) Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77:1241–1246CrossRefGoogle Scholar
  3. 3.
    Clavien PA, Petrowsky H, DeOliveira ML et al (2007) Strategies for safer liver surgery and partial liver transplantation. N Engl J Med 356:1545–1155CrossRefGoogle Scholar
  4. 4.
    LiverMetSurvey: International registry of patients operated for colorectal liver metastasis. Available at: http://www.livermetsurvey.orgGoogle Scholar
  5. 5.
    Schmoll HJ, Van Cutsem E, Stein A et al (2012) ESMO Consensus Guidelines for management of patients with colon and rectal cancer: a personalized approach to clinical and decision making. Ann Oncol 23:2479–2516CrossRefGoogle Scholar
  6. 6.
    May BJ, Madoff DC (2012) Portal vein embolization: rationale, technique, and current application. Semin Interv Radiol 29(2):81–89CrossRefGoogle Scholar
  7. 7.
    Shoup M, Gonen M, D'Angelica M, Jamagin WR, DeMatteo RP, Schwartz LH et al (2003) Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 7(3):325–330CrossRefGoogle Scholar
  8. 8.
    Viganò L, Capussotti L, Lapointe R, Barroso E, Hubert C, Giuliante F, Ijzermans JNM, Mirza DF, Elias D, Adam R (2014) Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based studyof 6,025 patients. Ann Surg Oncol 21:1276–1286CrossRefGoogle Scholar
  9. 9.
    Adam R (2003) Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. Ann Oncol 14(Suppl 2):13ii–1316iiCrossRefGoogle Scholar
  10. 10.
    Andres A, Toso C, Adam R, Barroso E, Hubert C, Capussotti L, Gerstel E, Roth A, Majno PE, Mentha G (2012) A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases: a LiverMetSurvey-based study. Ann Surg 256:772–779CrossRefGoogle Scholar
  11. 11.
    Akgül Ö, Çetinkaya E, Ersöz Ş, Tez M (2014) Role of surgery in colorectal cancer liver metastases. World J Gastroenterol 20(20):6113–6122CrossRefGoogle Scholar
  12. 12.
    Salah S, Watanabe K, Welter S, Park JS, Park JW, Zabaleta J, Ardissone F, Kim J, Riquet M, Nojiri K, Gisabella M, Kim SY, Tanaka K, al-Haj Ali B (2012) Colorectal cancer pulmonary oligometastases: pooled analysis and construction of a clinical lung metastasectomy prognostic model. Ann Oncol 23:2649–2655CrossRefGoogle Scholar
  13. 13.
    Cassidy J, Clarke S, Dıaz-Rubio E et al (2008) Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer. J Clin Oncol 26:2006–2012CrossRefGoogle Scholar
  14. 14.
    Somashekhar SP, Ashwin KR, Zaveri SS, Rauthan A, Patil P (2016) Assessment of tumor response and resection rates in unresectable colorectal liver metastases following neoadjuvant chemotherapy with cetuximab. Indian J Surg Oncol 7(1):11–17CrossRefGoogle Scholar
  15. 15.
    Pathak S, Jones R, Tang JM, Parmar C, Fenwick S, Malik H, Poston G (2011) Ablative ntherapies for colorectal liver metastases: a systematic review. Color Dis 13:252–265CrossRefGoogle Scholar
  16. 16.
    Jarnagin WR, Conlon K, Bodniewicz J, Dougherty E, DeMatteo RP, Blumgart LH et al (2001) A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases. Cancer 91:1121–1128CrossRefGoogle Scholar

Copyright information

© Indian Association of Surgical Oncology 2018

Authors and Affiliations

  1. 1.General SurgeryWestchester Medical CenterValhallaUSA
  2. 2.Department of SurgeryWestchester Medical CenterValhallaUSA

Personalised recommendations